Records containing: Prognostic Stage IV Breast Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-04-29A Phase I/II Study of the SV-BR-1-GM Regimen in HLA Matched Metastatic Breast Cancer Patients in Combination With Pembrolizumab
-
CLINICAL_TRIALS study record update · 2025-04-24A Phase II Trial of Sacituzumab Govitecan (IMMU-132) (NSC #820016) for Patients With HER2-Negative Breast Cancer and Brain Metastases
-
CLINICAL_TRIALS study record update · 2025-04-04IRENE Study: Phase 2 Study of INCMGA00012 and the Oncolytic Virus Pelareorep in Metastatic Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-02-25Phi29 Motor Nanopore for Single Molecule Sensing: Breast Nipple Aspirate Fluid
-
CLINICAL_TRIALS study record update · 2025-02-17A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-17Phase I/II Safety and Efficacy Study of Autophagy Inhibition With Hydroxychloroquine to Augment the Antiproliferative and Biological Effects of Pre-Operative Palbociclib Plus Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2025-01-17Phase 1 Feasibility Trial: Improved Staging of Lobular Breast Cancer With Novel Amino Acid Metabolic and Tumor Neovasculature Receptor Imaging
-
CLINICAL_TRIALS study record update · 2024-12-27INTERACT- Integrated Evaluation of Resistance and Actionability Using Circulating Tumor DNA in HR Positive Metastatic Breast Cancers
-
CLINICAL_TRIALS study record update · 2024-10-24Enhancing Immunotherapy by Targeting the EGFR Pathway in Inflammatory Breast Cancer: A Phase II Study of Panitumumab (PmAb) and Pembrolizumab (Pembro) in Combination With Neoadjuvant Chemotherapy (NAC) in Patients With Newly Diagnosed Triple Negative Inflammatory Breast Cancer (TN-IBC)
-
CLINICAL_TRIALS study record update · 2024-10-10Phase Ib Study of BYL719 (Alpelisib) in Combination With Androgen Receptor Inhibitor (Enzalutamide) in Patients With Androgen Receptor (AR)-Positive and PTEN Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-08-14Precision Pharmacogenomics in Cancer Patients
-
CLINICAL_TRIALS study record update · 2024-05-24Novel Dynamic PET Kinetics and MRI Radiomics Analyses in Brain Tumors
-
CLINICAL_TRIALS study record update · 2024-01-19Safety and Efficacy of Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy
-
CLINICAL_TRIALS study record update · 2023-12-27REINA: A Phase I Study of Radiation Enhanced IL 12-Necrosis Attraction in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2023-09-25A Phase 2 Study of Copanlisib (BAY 80-6946) in Combination With Fulvestrant in Patients With Metastatic Breast Cancer Progressing After Aromatase Inhibitor Plus CDK 4/6 Inhibitor
-
CLINICAL_TRIALS study record update · 2023-09-21A Phase I Study of AZD8186 in Combination With Docetaxel in Patients With PTEN Mutated or PIK3CB Mutated Advanced Solid Tumors, Potentially Amenable to Docetaxel
-
CLINICAL_TRIALS study record update · 2023-08-31Epigenetic Priming for Immune Therapy in ER-Positive Breast Cancer in Biomarker Select Population
-
CLINICAL_TRIALS study record update · 2023-04-10Breast Cancer Pathways Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
-
CLINICAL_TRIALS study record update · 2023-03-21A Phase I/IB Study of Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Patients With Metastatic Triple Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-02-08A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-01-06Cryoablation and Anti-PD-L1 Immunotherapy for Triple Negative Breast Cancer (TNBC)
-
CLINICAL_TRIALS study record update · 2022-11-15A Pilot Study of SGT-53 With Carboplatin and Pembrolizumab in Metastatic Triple Negative Inflammatory Breast Cancer
-
CLINICAL_TRIALS study record update · 2022-10-31A Phase Ib Trial of M7824 and Eribulin in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
-
CLINICAL_TRIALS study record update · 2022-06-09Comparative Effects of Ribociclib and Palbociclib on Circulating and Tumor Infiltrating Myeloid Cells in Metastatic Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2022-05-26Phase II Trial of Abemaciclib and T-DM1 in Women and Men With HER2-positive Advanced or Metastatic Breast Cancer Who Progressed on Treatment With a Taxane, Trastuzumab and Pertuzumab